Comparison of Iron Supplement Formulations to Improve Iron Status Following Roux-en-Y and Sleeve Gastrectomy Bariatric Surgery
N
Nana Gletsu Miller
Primary Investigator
Overview
The study team would like to learn the best form of over-the-counter iron supplementation for bariatric surgery patients who develop iron deficiency.
Description
The purpose of this study is to determine the effectiveness of various novel iron formulations versus ferrous sulfate for oral iron supplementation of iron deficient patient who have had RYGB or SG bariatric surgery.
Eligibility
You may be eligible for this study if you meet the following criteria:
-
Conditions:
bariatric surgery,iron deficency
-
Age: Between 18 Years - 65 Years
-
Gender: Female
Inclusion Criteria
Has a history of RYGB or SG bariatric surgery at least 6 months ago
Meets study conditions of being iron deficient
Exclusion Criteria
Pregnant
Currently under a treatment regiment that requires iron supplementation greater than standard of care
Has had parenteral iron less than one month before screening visit
Has history of hospitalization for acute illness in the previous one month
Has current active malignant neoplasm or history of malignancy other than localized basal cell cancer of skin during previous 5 years, and advice from oncologist that discourages them from participating in the the study
Has gastrointestinal disease that involves increased inflammation or blood loss
Has severe anemia
Taking erythropoietin stimulating medication or is on hemodialysis
Additional Information:Has a history of RYGB or SG bariatric surgery at least 6 months ago
Meets study conditions of being iron deficient
Exclusion Criteria
Pregnant
Currently under a treatment regiment that requires iron supplementation greater than standard of care
Has had parenteral iron less than one month before screening visit
Has history of hospitalization for acute illness in the previous one month
Has current active malignant neoplasm or history of malignancy other than localized basal cell cancer of skin during previous 5 years, and advice from oncologist that discourages them from participating in the the study
Has gastrointestinal disease that involves increased inflammation or blood loss
Has severe anemia
Taking erythropoietin stimulating medication or is on hemodialysis
This study takes place in Indianapolis, IN and West Lafayette, IN.
Participants will be compensated for their participation.
Updated on
25 Apr 2024.
Study ID: 1504248809